Cisplatin + Etoposide + Bleomycin

Regimen

• Cisplatin 20 mg/m2/d iv d1-5
• Etoposide (VP-16) 100 mg/m2/d iv d1-5
• Bleomycin 30 U iv d1, 8 and 15
• Q3w

References

Hainsworth JD et al. Cisplatin-based combination chemotherapy in the treatment of poorly differentiated carcinoma and poorly-differentiated adenocarcinoma of unknown primary site: results of a 12-year experience. J Clin Oncol 1992; 10:912